Dupuytren Contractures: An Update of Recent Literature.

J Hand Surg Am · Oct 2021 · Review

Boe C, Blazar P, Iannuzzi N

Department of Orthopaedics & Sports Medicine, University of Washington, Seattle, WA

Hand & Upper Extremity

SUMMARY — THE REDUCTIONThis review updates recent literature on Dupuytren contracture pathophysiology and treatment, highlighting growing use of collagenase injection alongside needle aponeurotomy and fasciectomy.
Abstract, as published

Dupuytren disease is a fibroproliferative disorder that affects the palmar fascia of the hand and results in varying degrees of nodule and cord formation. Over time, patients may develop progressive contractures, impairing their ability to type, to perform with fine instruments, or to participate in social activities such as shaking hands. Treatment options for Dupuytren contractures include needle aponeurotomy (NA), injection of collagenase Clostridium histolyticum (CCH) with manipulation of the digits, and surgical fasciectomy. Over the past decade, the use of CCH has increased. Recent studies have provided additional data regarding the pathophysiology, indications, outcomes, and costs associated with the treatment for Dupuytren contractures, and this review highlights these advances.

Featured in the 2026-09-06 issue.

← Substance Addiction and the Hand Surgery Patient: A Comprehen…Metacarpal and Phalangeal Malunions-Is It all About the Rotat… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.